New Drug-Radiation combo tested for tough pancreatic tumors
Disease control
Recruiting now
This early-stage study is testing whether a new drug called XER-001, delivered directly to the small intestine, can be safely combined with precise radiation therapy for pancreatic cancer that hasn't spread. Researchers want to find the best dose and see if this combination helps…
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC